FluroTech Appoints a New Chief Financial Officer and a Vice President of Business Development

FluroTech (TSXV:TEST), (“FluroTech” or the “Company”) is pleased to introduce Mr. Curtis Smith as Chief Financial Officer taking over responsibilities from Mr. Gary Jones, who has been appointed Vice President of Business Development.

Over the past three years Mr. Smith led the finance team at Eguana Technologies Inc, a TSX-V and OTCQB traded company, where he restructured the finance group to prepare the company for its transition to a globally-recognized technology leader in power conversion and control systems for distributed energy storage. Previously, he guided a private cold press juice company from conceptualization to a national brand leader as well as leading the finance team at a Calgary based oil field service company through a merger and integration process with a billion-dollar acquirer. His career began in the entrepreneurship group at KPMG, where Mr. Smith was an audit manager.

“Mr. Smith has demonstrated success in each stage of his career. He brings an extensive background in financial reporting, regulatory controls and capital markets, as well as, an in-depth knowledge of what it takes to bring a Company from conceptualization to profitability,” stated Danny Dalla-Longa, FluroTech’s Chief Executive Officer. “Mr. Jones was pivotal in helping the Company raise $11.2 million and leading the Company’s public listing on the TSX-V. We are excited for him to deploy his extensive sales and leadership skills in the commercialization of the CompleTestTM product.”

Prior to FluroTech, Mr. Jones was one of the Managing Partners for a Private Equity firm involved in the Energy Sector. Gary still serves as a Director for a number of Canadian private companies. He has also served as Vice-President, Investment Counsellor for one of Canada’s major Financial Institutions.

About FluroTech (TSXV: TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech‘s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com.

Contact Information

FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com

Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com

Cannot view this image? Visit:
https://orders.newsfilecorp.com/files/5928/40758_fllogo.jpg

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about commercialization of the CompleTest™ device, and the future performance of the Company.

The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis industry in general, and failure to meet certain timelines for commercialization. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.

The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Click here to connect with FluroTech (TSXV:TEST) for an Investor Presentation.

Source: www.newsfilecorp.com